A Study to Assess the Safety of a New Inserter Device for Paragard® (Intrauterine Copper Contraceptive)

* Subject is a postmenarcheal and premenopausal woman of child bearing potential.

* Subjects are at least 18 years of age, at the time of signing the informed consent.

* Subject is overtly healthy as determined by medical evaluation.

* Pregnancy or suspicion of pregnancy or at risk for luteal phase pregnancy

* History of previous IUD complications

* Abnormalities of the uterus resulting in distortion of the uterine cavity that may complicate IUD insertion

* Known anatomical abnormalities of the cervix

* Presence of acute pelvic inflammatory disease at the time of screening.

* Postpartum endometritis.

* Known or suspected uterine or cervical malignancy.

* Uterine bleeding of unknown etiology.

* Untreated acute cervicitis or vaginitis or other lower genital tract infection.

* Conditions associated with increased susceptibility to pelvic infections.

* Subjects with Wilson's disease.